This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

The Effect of Gabapentin, Ketamine and Dexamethasone on Pain and Opioid Requirements After Hip Surgery

This study has been terminated.
(Structural changes that stopped the type of operations used in the study)
Information provided by:
Glostrup University Hospital, Copenhagen Identifier:
First received: October 7, 2005
Last updated: May 14, 2008
Last verified: May 2008
Patients scheduled for primary hip replacement needs postoperative pain treatment, i.e. morphine. Morphine has side-effects: nausea, vomiting, sedation and dizziness. These side-effects are unpleasant for the patients and sometimes keeps them at bed longer time than needed. We investigate in new combinations of analgesics for postoperative pain, hoping to minimize the need for morphine.

Condition Intervention Phase
Pain, Postoperative Drug: Gabapentin + dexamethasone + ketamine Drug: Placebo Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: The Effect of Gabapentin, Low Dose Ketamine, Paracetamol, NSAID and Dexamethasone on Pain and Opioid Requirements in Patients Scheduled for Primary Total Hip Replacement

Resource links provided by NLM:

Further study details as provided by Glostrup University Hospital, Copenhagen:

Primary Outcome Measures:
  • The total amount of morphine needed postoperatively from 0-4h; and 0-24h, administered by a patient controlled pain treatment.(PCA) [ Time Frame: 0-24h ]

Secondary Outcome Measures:
  • Pain score (VAS)= at rest and at mobilisation. [ Time Frame: 0-24h ]
  • Postoperative Nausea and vomiting. [ Time Frame: 0-24h ]
  • Dizziness [ Time Frame: 0-24h ]
  • Sedation [ Time Frame: 0-24h ]
  • Nightmare and hallucinations. [ Time Frame: 0-24h ]
  • All measurements are taken at 2,4 and 24 h postoperatively. [ Time Frame: 0-24h ]

Enrollment: 48
Study Start Date: October 2005
Study Completion Date: May 2008
Primary Completion Date: April 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1 Drug: Gabapentin + dexamethasone + ketamine
Comparing analgesic effect of gabapentin 1200 mg + dexamethasone 8 mg + ketamine 0.15 mg/kg
Other Names:
  • Anti-hyperalgesics
  • Postoperative pain
Placebo Comparator: 2 Drug: Placebo
Matching placebo

Detailed Description:
The effect on postoperative pain of the combination of preoperative gabapentin 1200 mg + dexamethasone 8 mg + ketamine 0.15mg/kg versus placebo is investigated on patients having a hip alloplastic operation.

Ages Eligible for Study:   55 Years to 85 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients scheduled for primary total hip replacement,
  • Between 55 and 85 years of age,
  • ASA 1-3 and BMI between 18 and 35.

Exclusion Criteria:

Patients who are:

  • Unable to cooperate
  • Does not speak Danish
  • Has allergy for drugs used in the trial
  • Drug or alcohol abuse
  • Epilepsy
  • Medically treated diabetes
  • Known kidney disease
  • Daily use of analgetics
  • Apart from NSAID
  • Paracetamol or COX2 inhibitors
  • Are treated with a antidepressive.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00236223

Operations og Anæstesiologisk afd. Y, KAS Glostrup
Glostrup, Denmark, 2600
Anæstesiafdelingen, Herning Centralsygehus
Herning, Denmark, 7400
Sponsors and Collaborators
Glostrup University Hospital, Copenhagen
Principal Investigator: Ole Mathiesen, MD Department of Anaesthesiology, Copenhagen University Hospital in Glostrup, 2600 Glostrup, Denmark
  More Information

Responsible Party: Ole Mathiesen, Dept of anaesthesiology Identifier: NCT00236223     History of Changes
Other Study ID Numbers: SM2-05
Study First Received: October 7, 2005
Last Updated: May 14, 2008

Keywords provided by Glostrup University Hospital, Copenhagen:
Primary hip replacement
Multimodal postoperative analgesia.

Additional relevant MeSH terms:
Pain, Postoperative
Neurologic Manifestations
Nervous System Diseases
Postoperative Complications
Pathologic Processes
Signs and Symptoms
Dexamethasone acetate
BB 1101
gamma-Aminobutyric Acid
Anti-Inflammatory Agents
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Gastrointestinal Agents
Hormones, Hormone Substitutes, and Hormone Antagonists
Antineoplastic Agents, Hormonal
Antineoplastic Agents
Protease Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Sensory System Agents
Anesthetics, Dissociative processed this record on August 21, 2017